New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
about
Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat modelThe targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging.Protective effect of COMP-angiopoietin-1 on cyclosporine-induced renal injury in mice.Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidneyRenal transplantation in patients with HIV.Urotensin II levels in patients with chronic kidney disease and kidney transplants.Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.Insights into the possible mechanism of cyclosporine-induced chronic nephrotoxicity; arteriolopathyNephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosisDeletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration.Summary of the US FDA approval of belatacept.Exercise limitation following transplantation.Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.Ultrastructural examination of renal tubular epithelial cells and hepatocytes in the course of chronic cyclosporin A treatment--a possible link to oxidative stress.Electrolyte and Acid-base disturbances induced by clacineurin inhibitors.Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients.The safety of calcineurin inhibitors for kidney-transplant patients.Pilot study: use of contrast-enhanced ultrasonography in feline renal transplant recipients.Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity.Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.Effect of Isoproterenol on LDL Susceptibility to Oxidation and Serum Total Antioxidant Capacity in Cyclosporine-Treated Rats.Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model.Defining a microRNA-mRNA interaction map for calcineurin inhibitor induced nephrotoxicity.Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.MicroRNA-494 promotes cyclosporine-induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN.Alport syndrome: the effects of spironolactone on proteinuria and urinary TGF-β1.Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation.Cyclosporin A-induced gingival overgrowth is not associated with myofibroblast transdifferentiation.Expression of ammonia transporters, Rhbg and Rhcg, in chronic cyclosporine nephropathy in rats.Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
P2860
Q28541349-C7F3F94B-812F-4EA6-90C0-3D83095CBB5CQ30859470-521BC308-E9F8-4F78-B45F-048C5889EF81Q33332423-B86F096D-F1AC-4372-9DDC-F43B271350FAQ33750173-CC122030-8078-4615-B42F-61E09E0FB70EQ34079397-112A02D7-D352-4B17-A837-C3ABDE42429DQ35764893-58C10FA4-AE68-4F9F-9E0D-8689A2ED4353Q35992464-9C000535-75B1-4582-9978-3232DB17F2B1Q36617869-EFD85A6D-0711-4DA1-B1A3-54BADA45E996Q36734313-0B5278ED-0624-4A03-ABB0-34900A87AA3CQ37175582-D338645B-342C-42BF-AB9F-35C2D066DAD9Q37279488-5B70E639-7942-48E4-A77B-E6498A7B8425Q37984076-F951A3BD-EE7E-45BA-BEF2-44FD5B6C5C18Q38110753-5B55725A-989A-4614-A3E4-F3E6C1C859B2Q38116657-2CE03FBF-0443-4CF8-BE70-05FDBD0EA0E0Q38123233-4CACFAB4-03C2-4427-97C6-F971395BD119Q38181480-82BBBA6E-B612-47C8-B71F-545477D98C4FQ38435024-5CF7A1E6-93EF-411B-891A-DF81ACAAB71BQ38578386-1A3EEEDC-9C56-49A1-AA4F-E513EF5895F8Q38722810-35E7ABF2-7E1D-430A-A81E-A1431E2185A4Q38817871-86D603C6-09FA-43E3-9E8C-4ADA4A3EE7EAQ39270508-06FF815B-BB03-48EF-ABAF-7EFE78D456B7Q39304722-80FE8B56-AAE8-4F60-813A-1C574DEE49E1Q40188939-0D51F2FC-F99D-4D0E-B91A-49F632B7E6B9Q41488466-2B54947A-4175-4137-BBE2-36D2DE5D9D8BQ41839997-2BAB1253-BFC6-48FA-B5B9-E0152407A480Q42773419-576B0466-A2E4-4F57-8B1D-EC4151EDA245Q42777770-8158AA90-2CD6-4CC0-A3AD-DABADA637351Q48242270-00A75BBC-1A9C-4986-966E-A61357C31FC0Q50592626-581F5D0B-BEA7-4B80-9F7C-D90CF4EF084FQ50925186-4D11DD1E-8EBC-42A2-BE6F-4CB164697FD1Q51317388-93C1AF35-76D8-4736-9C03-8CB93C48D64AQ54418414-524378A8-EAF2-4FF6-B6A9-4563C010FDD4Q55402405-AB8C320B-FCC1-4D6C-981A-F79FFD1C8F3EQ57151742-222FE254-AA6D-4986-BB0A-B9483268269D
P2860
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New insights into the pathophy ...... xicity: a role of aldosterone.
@ast
New insights into the pathophy ...... xicity: a role of aldosterone.
@en
type
label
New insights into the pathophy ...... xicity: a role of aldosterone.
@ast
New insights into the pathophy ...... xicity: a role of aldosterone.
@en
prefLabel
New insights into the pathophy ...... xicity: a role of aldosterone.
@ast
New insights into the pathophy ...... xicity: a role of aldosterone.
@en
P2860
P1476
New insights into the pathophy ...... oxicity: a role of aldosterone
@en
P2093
Norma A Bobadilla
P2860
P356
10.1152/AJPRENAL.00072.2007
P577
2007-04-11T00:00:00Z